Stock Events

Stock Events

Galderma Group 

€172
0
+€1+0.58% Today

Statistics

Day High
0
Day Low
0
52W High
180
52W Low
101
Volume
0
Avg. Volume
13
Mkt Cap
0
P/E Ratio
-
Dividend Yield
0.04%
Dividend
0.07

Upcoming

24
APR
Dividend Ex
Increased
 
27
APR
Dividend Ex
Estimated
 
28
APR
Dividend Payment
Increased
 
1
MAY
Dividend Payment
Estimated
 
26
APR 27
Dividend Ex
Estimated
 

Dividends

0.04%Dividend Yield
May 26
€0.07
Apr 26
€0.38
Apr 25
€0.07
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

23JulExpected
Q4 2025
Next
1.35
1.55
1.74
1.94
Expected EPS
1.9369603813999998
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PY3.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap574.66B
Johnson & Johnson offers a wide range of skincare products through its consumer health division, directly competing with Galderma's offerings in the dermatological care market.
Novartis
NVS
Mkt Cap297.35B
Novartis, former parent company of Galderma, has a strong presence in the healthcare sector, including dermatology, competing in therapeutic areas similar to Galderma.
Pfizer
PFE
Mkt Cap153.13B
Pfizer competes in the pharmaceuticals sector including dermatology, offering products that overlap with Galderma’s therapeutic solutions.
Merck
MRK
Mkt Cap300.2B
Merck operates in the healthcare and pharmaceutical sectors with products that compete in dermatological conditions, a key area for Galderma.
Bristol-Myers Squibb
BMY
Mkt Cap119.69B
Bristol-Myers Squibb competes in various therapeutic areas including those that overlap with Galderma’s dermatology-focused portfolio.
Lilly(Eli) &
LLY
Mkt Cap840.84B
Eli Lilly competes in the pharmaceutical field with a focus on medical dermatology, offering treatments that can compete with Galderma’s products.
GSK
GSK
Mkt Cap116.3B
GlaxoSmithKline has a diversified healthcare portfolio that includes skin health products, competing with Galderma in the dermatology market.
Astrazeneca
AZN
Mkt Cap316.3B
AstraZeneca operates broadly in the pharmaceutical sector, including areas that compete with Galderma’s dermatological treatments.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.17B
Regeneron Pharmaceuticals focuses on innovative treatments, including for skin diseases, which puts it in competition with Galderma’s dermatology products.

About

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Show more...
CEO
Dr. Flemming Ornskov M.B.A., M.D., M.P.H.
Employees
7676
Country
Switzerland
ISIN
CH1335392721

Listings

MX
MX
GALDN.MX
F
DE
PY3.F
MI
IT
1GALD.MI
MU
DE
PY3.MU

0 Comments

Share your thoughts

FAQ

What is Galderma Group stock price today?▼
The current price of PY3.MU is €172 EUR — it has increased by +0.58% in the past 24 hours. Watch Galderma Group stock price performance more closely on the chart.
What is Galderma Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Galderma Group stocks are traded under the ticker PY3.MU.
When is the next Galderma Group earnings date?▼
Galderma Group is going to release the next earnings report on July 23, 2026.
What were Galderma Group earnings last quarter?▼
PY3.MU earnings for the last quarter are 1.74 EUR per share, whereas the estimation was 1.35 EUR resulting in a +28.78% surprise. The estimated earnings for the next quarter are N/A EUR per share.
Does Galderma Group pay dividends?▼
Yes, PY3.MU dividends are paid annual. The last dividend per share was 0.07 EUR. As of today, Dividend Yield (FWD)% is 0.04%.
How many employees does Galderma Group have?▼
As of April 14, 2026, the company has 7,676 employees.
In which sector is Galderma Group located?▼
Galderma Group operates in the Other sector.
When did Galderma Group complete a stock split?▼
Galderma Group has not had any recent stock splits.
Where is Galderma Group headquartered?▼
Galderma Group is headquartered in Zug, Switzerland.